Lung Cancer Video Library - Gilotrif/ Afatinib in Squamous NSCLC

dbrock's picture

Submitted by dbrock on Thu, 05/24/2018 - 16:10

Vamsidhar Velcheti, MD, GRACE Faculty

 

Dr. Vamsidhar Velcheti, Thoracic Oncologist, Hematology and Medical Oncology, Cleveland Clinic, joined GRACE to discuss updates to our Lung Cancer Video Library. In this video, Dr. Velcheti discusses gilotrif/afatanib in squamous non small cell lung cancer.

We would like to thank the following companies for their support of this program

 

 

                

 

 

                        

 

 
 

 

 

  

Related Content: 
Gilotrif (Afatinib) Reports Survival Benefit for EGFR Mutation-Positive Advanced NSCLC: Is it a Superior EGFR Inhibitor?
Does Gilotrif Help EGFR Positive Lung Cancer Patients?
Are There Clinically Significant Differences Among the First and Second Generation EGFR TKIs (Iressa, Tarceva, Gilotrif)?
Lung Cancer Video Library - Gilotrif/ Afatinib in Squamous NSCLC
Video Language: 
English

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation